ENVERIC BIOSCIENCES, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $4.24M, a 1563.80% increase year-over-year.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $255.11K.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, new issues for the quarter ending 2020-12-31 was -$968.48K.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, new issues for the quarter ending 2020-09-30 was $0.00.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, new issues for fiscal 2025 was $4.24M.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, new issues for fiscal 2023 was $255.11K.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, new issues for fiscal 2020 was $756.52K, a 258.74% increase from fiscal 2019.
- ENVERIC BIOSCIENCES, INC. stock issued during period, value, new issues for fiscal 2019 was $210.89K.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $4.24M 10-K · filed 2026-03-27 | |
| 2025-03-31 | $4.24M 10-Q · filed 2026-08-14 | |
| 2024-03-31 | $255.11K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $255.11K 10-K · filed 2025-03-28 | |
| 2020-12-31 | -$968.48K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $756.52K 10-K · filed 2022-03-31 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | |
| 2019-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-08-12 | $210.89K 10-K/A · filed 2020-08-12 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | |
| 2017-12-31 | $4.88M 10-K · filed 2019-03-26 | |
| 2016-12-31 | $3.00M 10-K · filed 2018-04-02 | |
| 2011-12-31 | $87.45K 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |